NASDAQ : IMDX
Insight Molecular Diagnostics Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 3.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 104.06M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 90.97M |
| Enterprise Value | 75.84M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 32.72M |
| Shares Outstanding | 32.72M |
| Shares Change (YoY) | +52.34% |
| Shares Change (QoQ) | +6.46% |
| Owned by Insiders (%) | 12.29% |
| Owned by Institutions (%) | 10.15% |
| Float | 9.98M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.00 |
| Forward PS | 53.82 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 48.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.00 |
| Quick Ratio | 1.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -377.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -57.82% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -193.07% |
| Weighted Average Cost of Capital (WACC) | 13.88% |
| Revenue Per Employee | $28,793 |
| Profits Per Employee | -$851,017 |
| Employee Count | 58 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.90 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -49.92% |
| 50-Day Moving Average | 3.62 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 41.55 |
| Average Volume (20 Days) | 240,421 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 949,512 |
| Short Previous Month | 973,029 |
| Short % of Shares Out | 2.90% |
| Short % of Float | 9.52% |
| Short Ratio (days to cover) | 3.00 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.67M |
| Gross Profit | 814,000 |
| Operating Income | -36.99M |
| Pretax Income | -49.36M |
| Net Income | -49.36M |
| EBITDA | -34.54M |
| EBIT | -36.99M |
| Loss Per Share | -$1.46 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 17.76M |
| Total Debt | 2.63M |
| Net Cash | 15.13M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | -21.30M |
| Book Value Per Share | -0.65 |
| Working Capital | 10.26M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -27.08M |
| Capital Expenditures | -3.92M |
| Depreciation & Amortization | 2.44M |
| Net Borrowing | -593,000 |
| Free Cash Flow | -31.00M |
| FCF Per Share | -$0.95 |
Margins
| Measure | Value |
|---|
| Gross Margin | 48.74% |
| Operating Margin | -2,214.73% |
| Pretax Margin | -2,955.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -52.34% |
| Shareholder Yield | -52.34% |
| Earnings Yield | -52.44% |
| FCF Yield | -32.00% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.25 |
| Price Target Difference | 196.76% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 88.71% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 25, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -21.76 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |